Avania announces Jason Monteleone, one of the candidates CRO and Führer of MedTech Industry, as its new Chairman and CEO Page 1

Avania – the well-known medical medical technology division for clinical studies (CRO), the product development, market and clinical research methods are offered – the experience of Jason Monteleone will start on September 2, 2024 with his presidency and CEO with the work. Monteleone started the Nachfolge von Sapna Hornyak in 2019 as chairman and CEO war. Under the Hornyaks development Avania has developed a large, integrated global MedTech platform, Jason Monteleone has developed through growth initiatives a deep therapeutic specialization and innovation in a different way, an Avania’s position as the most successful MedTech CRO for the future.

This press conference resulted in a multimedia inhalation. The complete Mitteilung can be found here: https://www.businesswire.com/news/home/20240904600517/de/